Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech graveyard
Biotech
Oncternal sells cancer assets to mystery biotech, winds down ops
Oncternal’s ROR1 programs have gone out with a whimper, offloaded to Ho’ola Therapeutics for $3 million upfront as the biotech winds down operations.
Nick Paul Taylor
Jul 1, 2025 9:38am
CEO props up Aptose's finances to keep biotech from going bust
Jun 17, 2025 10:04am
Adios, iTeos: Biotech folds weeks after GSK TIGIT termination
May 28, 2025 9:19am
Vor Bio to wind down, laying off most staff
May 8, 2025 10:50am
Third Harmonic’s song to end as biotech looks to liquidate
Apr 14, 2025 9:01am
Vincerx prepares to wind down as final merger attempt collapses
Apr 9, 2025 7:55am
